Other
P-HYDROXYANISOLE
Safety score · 0–100
Moderate
Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.
A phenolic antioxidant (MEHQ) used as a polymerization inhibitor and skin conditioning agent; restricted under EU Annex III (III/95) due to endocrine-disrupting concerns and sensitization.
4-Hydroxyanisole (MEHQ) serves dual functions in cosmetics as a polymerization inhibitor for monomers and as a skin conditioning agent with antioxidant properties. However, the compound has demonstrated endocrine-disrupting activity in toxicological studies, raising concerns about its safety in leave-on cosmetic products. EU Regulation 1223/2009 Annex III listing (reference III/95) restricts its use to specified concentration limits and prohibits use in certain product types. The phenol structure contributes to skin irritation potential, and the SCCS has noted that the risk-benefit ratio for cosmetic use requires careful evaluation given the availability of safer alternatives.
Skin benefits
- Antioxidant skin conditioning properties
- Polymerization inhibition in cosmetic formulations
Known concerns
- EU Annex III restriction (III/95) for endocrine-disrupting potential
- Skin sensitization and irritation reported
- Endocrine disruption concern identified by SCCS
- Limited to specific product types and concentrations in EU
References
EU CosIng database
European Commission cosmetic ingredient registry: regulatory status, restrictions, authorised functions.
Related others
Check your shelf
Find P-HYDROXYANISOLE in your products.
Scan any cosmetic product with LuxSense to see if it contains P-HYDROXYANISOLE and get a full ingredient breakdown with safety scores.
This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve, so always read the physical product label and consult a healthcare professional for personal concerns.